Sigrid Bladel - Profile and Investment Details

Investor Profile

Sigrid Bladel is a Venture Capital based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Alibris, goBalto, Kit Check, Eledon Pharmaceuticals, Salmedix Inc, Avera Pharmaceutical, Rock Health, Gravie, Wello, Anacor Pharmaceutical, Posit Science, NxThera, KAI Pharmaceuticals, Microbia, CapitalThinking, Advance Medical, VertiFlex, Nevro, Ablation Frontiers, Omada Health, Aviir, Sequoia Pharmaceuticals, Cricket HealthPharmion, Cervel Neurotech, Clovis Oncology, MC10, Conatus Pharmaceuticals, Autonomic Technologies, Jiff, Paracor Medical, NBI Development, Viracta Therapeutics, Adavium, RxAnte, Mpex Pharmaceuticals, . Over time, Sigrid Bladel has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Sigrid Bladel is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Hospitals, Wellness, Women Founded, Mobile, Software, Biotechnology, Clinical Trials, Hardware, Insurance, Medical, SaaS may find it worthwhile to explore potential connections with Sigrid Bladel, as their portfolio suggests a familiarity and interest in this area.

Understanding Sigrid Bladel’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.